Literature DB >> 8430638

Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome.

P Cacoub1, R Dorent, G Maistre, P Nataf, A Carayon, C Piette, P Godeau, C Cabrol, I Gandjbakhch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8430638     DOI： 10.1016/0002-9149(93)90452-i

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  20 in total

1.  EndothelinB receptor-mediated contraction in human pulmonary resistance arteries.

Authors:  K M McCulloch; C C Docherty; I Morecroft; M R MacLean
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 2.  Pulmonary arterial hypertension: a comparison between children and adults.

Authors:  R J Barst; S I Ertel; M Beghetti; D D Ivy
Journal:  Eur Respir J       Date:  2011-03       Impact factor: 16.671

Review 3.  The clinical potential of endothelin receptor antagonists in cardiovascular medicine.

Authors:  C J Ferro; D J Webb
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 4.  The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

Authors:  Natalie Hopkins; Paul McLoughlin
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

5.  Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation.

Authors:  D D Ivy; J P Kinsella; S H Abman
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro.

Authors:  J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

Review 7.  Endothelins. A potential target for pharmacological intervention in diseases of the elderly.

Authors:  H Lévesque; N Moore; N Cailleux; V Richard; C Thuillez; H Courtois
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

8.  Pulmonary hypertension: diagnosis and management.

Authors:  Michael D McGoon; Garvan C Kane
Journal:  Mayo Clin Proc       Date:  2009-02       Impact factor: 7.616

9.  Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management.

Authors:  Jennifer Cowger Matthews; Vallerie McLaughlin
Journal:  Curr Cardiol Rev       Date:  2008-02

10.  Ambrisentan for the treatment of pulmonary arterial hypertension.

Authors:  Brian Casserly; James R Klinger
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.